Approval · Notice of Compliance 15022 · 2013
GRASTEK: Notice of Compliance 15022
Issued December 12, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15022
- Date
- December 12, 2013
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Allergy immunotherapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GRASTEK | 02418304 | Marketed |
Medicinal ingredients
- STANDARDIZED TIMOTHY GRASS POLLEN 75,000 UNIT per TAB